Nano Mobile Healthcare Stock Current Valuation
VNTH Stock | USD 0.0002 0.0001 100.00% |
Valuation analysis of Nano Mobile Healthcare helps investors to measure Nano Mobile's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Nano Mobile's price fluctuation is out of control at this time. Calculation of the real value of Nano Mobile Healthcare is based on 3 months time horizon. Increasing Nano Mobile's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nano Mobile is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nano Pink Sheet. However, Nano Mobile's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.0E-4 | Real 1.57E-4 | Hype 1.47E-4 | Naive 1.98E-4 |
The intrinsic value of Nano Mobile's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Nano Mobile's stock price.
Estimating the potential upside or downside of Nano Mobile Healthcare helps investors to forecast how Nano pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nano Mobile more accurately as focusing exclusively on Nano Mobile's fundamentals will not take into account other important factors: Nano Mobile Healthcare Company Current Valuation Analysis
Nano Mobile's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Nano Mobile Current Valuation | 1.75 M |
Most of Nano Mobile's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nano Mobile Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Nano Mobile Healthcare has a Current Valuation of 1.75 M. This is 99.99% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Nano Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nano Mobile's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nano Mobile could also be used in its relative valuation, which is a method of valuing Nano Mobile by comparing valuation metrics of similar companies.Nano Mobile is currently under evaluation in current valuation category among its peers.
Nano Fundamentals
Return On Asset | -15.78 | |||
Current Valuation | 1.75 M | |||
Shares Outstanding | 803.66 M | |||
Shares Owned By Insiders | 12.82 % | |||
Price To Earning | (0.01) X | |||
EBITDA | (1.31 M) | |||
Net Income | (4.6 M) | |||
Cash And Equivalents | 485 | |||
Debt To Equity | 0.64 % | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (1.59 M) | |||
Earnings Per Share | (0.03) X | |||
Beta | -0.63 | |||
Market Capitalization | 482.19 K | |||
Total Asset | 10.3 K | |||
Retained Earnings | (16.77 M) | |||
Working Capital | (11.81 M) | |||
Current Asset | 58 K | |||
Current Liabilities | 11.87 M | |||
Net Asset | 10.3 K |
About Nano Mobile Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nano Mobile Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nano Mobile using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nano Mobile Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
EBR | Centrais Electricas Brasileiras | |
HE | Hawaiian Electric Industries | |
VFC | VF Corporation | |
BVHMF | Vistry Group PLC | |
S | SentinelOne |
Other Information on Investing in Nano Pink Sheet
Nano Mobile financial ratios help investors to determine whether Nano Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nano with respect to the benefits of owning Nano Mobile security.